Physician profile
Martin E Hilton
NPI 1508992579
$5,626.98
in general payments reported to CMS, 2019-2025
16 companies · $70.53 in 2025
The $70.53 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,831 · 2020: $72.41 · 2021: $1,323 · 2022: $171 · 2023: $90.57 · 2024: $68.31 · 2025: $70.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $229.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,708.73 | 2019 | |
| Pylant Medical | $2,073.14 | 2019-2021 | |
| Stryker Corporation | $235.09 | 2019-2023 | Mako |
| Bioventus LLC | $126.66 | 2021-2025 | Durolane, Durolane |
| Depuy Synthes Sales INC. | $110.60 | 2019-2025 | Orthovisc, Monovisc, Truespan Orthocord |
| Medacta USA, INC. | $90.37 | 2022 | |
| Alafair Biosciences, INC. | $63.55 | 2022 | |
| Medtronic USA, INC. | $41.77 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $40.38 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $28.20 | 2019 | |
| Axogen | $26.64 | 2020 | |
| Vericel Corporation | $21.93 | 2021 | |
| Smith+Nephew, INC. | $17.17 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $16.90 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $13.42 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $12.43 | 2023 | Evoke Scs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Hilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.